Profile | GDS5420 / 212004_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 1100.4 | 80 |
GSM1296119 | B_lesional_pre-dose | 2206.67 | 90 |
GSM1296076 | C_lesional_pre-dose | 1734.32 | 86 |
GSM1296092 | D_lesional_pre-dose | 1708.87 | 86 |
GSM1296103 | E_lesional_pre-dose | 1415.1 | 84 |
GSM1296078 | F_lesional_pre-dose | 1625.4 | 86 |
GSM1296107 | G_lesional_pre-dose | 1846.46 | 88 |
GSM1296109 | H_lesional_pre-dose | 1600.56 | 87 |
GSM1296080 | I_lesional_pre-dose | 409.26 | 65 |
GSM1296090 | J_lesional_pre-dose | 1994.87 | 89 |
GSM1296074 | K_lesional_pre-dose | 1965.68 | 88 |
GSM1296111 | L_lesional_pre-dose | 1921.76 | 89 |
GSM1296099 | M_lesional_pre-dose | 1508.8 | 85 |
GSM1296086 | O_lesional_pre-dose | 1326.7 | 83 |
GSM1296117 | P_lesional_pre-dose | 2175.44 | 90 |
GSM1296113 | Q_lesional_pre-dose | 2014.53 | 90 |
GSM1296096 | R_lesional_pre-dose | 1810.35 | 88 |
GSM1296105 | S_lesional_pre-dose | 923.07 | 78 |
GSM1296098 | T_lesional_pre-dose | 753.03 | 74 |
GSM1296101 | U_lesional_pre-dose | 968.98 | 79 |
GSM1296121 | V_lesional_pre-dose | 1813.61 | 88 |
GSM1296088 | W_lesional_pre-dose | 1289.97 | 83 |
GSM1296082 | X_lesional_pre-dose | 1928.84 | 88 |
GSM1296115 | Y_lesional_pre-dose | 1963.35 | 89 |
GSM1296084 | Z_lesional_pre-dose | 884.45 | 77 |
GSM1296072 | B_lesional_day8 | 1648.42 | 87 |
GSM1296069 | L_lesional_day8 | 1800.7 | 89 |
GSM1296071 | P_lesional_day8 | 1435.81 | 85 |
GSM1296070 | Y_lesional_day8 | 1541.29 | 86 |
GSM1296073 | V_lesional_day8 | 2278.36 | 90 |
GSM1296034 | A_lesional_day15 | 362.22 | 61 |
GSM1296041 | G_lesional_day15 | 1797.83 | 88 |
GSM1296035 | R_lesional_day15 | 1802.9 | 88 |
GSM1296038 | U_lesional_day15 | 1443.04 | 85 |
GSM1296047 | B_lesional_day15 | 1514.81 | 86 |
GSM1296039 | E_lesional_day15 | 2241.41 | 90 |
GSM1296042 | H_lesional_day15 | 1727.73 | 88 |
GSM1296043 | L_lesional_day15 | 1384.23 | 85 |
GSM1296037 | M_lesional_day15 | 1080.96 | 81 |
GSM1296046 | P_lesional_day15 | 1299.72 | 84 |
GSM1296044 | Q_lesional_day15 | 1662.65 | 88 |
GSM1296045 | Y_lesional_day15 | 1519.95 | 86 |
GSM1296025 | C_lesional_day15 | 415.84 | 65 |
GSM1296033 | D_lesional_day15 | 853.04 | 76 |
GSM1296027 | I_lesional_day15 | 736.12 | 74 |
GSM1296032 | J_lesional_day15 | 868.99 | 77 |
GSM1296024 | K_lesional_day15 | 259.13 | 57 |
GSM1296031 | W_lesional_day15 | 947.13 | 78 |
GSM1296028 | X_lesional_day15 | 841.04 | 76 |
GSM1296029 | Z_lesional_day15 | 649.81 | 72 |
GSM1296026 | F_lesional_day15 | 593.55 | 71 |
GSM1296030 | O_lesional_day15 | 1065.87 | 80 |
GSM1296040 | S_lesional_day15 | 1206.49 | 82 |
GSM1296036 | T_lesional_day15 | 681.62 | 72 |
GSM1296048 | V_lesional_day15 | 1894.93 | 88 |
GSM1296059 | A_lesional_day43 | 1553.69 | 86 |
GSM1296066 | G_lesional_day43 | 1623.6 | 87 |
GSM1296060 | R_lesional_day43 | 1322.08 | 83 |
GSM1296063 | U_lesional_day43 | 1806.06 | 88 |
GSM1296064 | E_lesional_day43 | 2085.48 | 89 |
GSM1296067 | H_lesional_day43 | 1098.14 | 81 |
GSM1296062 | M_lesional_day43 | 971.55 | 78 |
GSM1296068 | Q_lesional_day43 | 1514.21 | 86 |
GSM1296050 | C_lesional_day43 | 855.63 | 77 |
GSM1296057 | D_lesional_day43 | 1798.42 | 88 |
GSM1296052 | I_lesional_day43 | 801.52 | 75 |
GSM1296054 | J_lesional_day43 | 517.72 | 68 |
GSM1296049 | K_lesional_day43 | 419.76 | 65 |
GSM1296055 | W_lesional_day43 | 1885.36 | 89 |
GSM1296053 | X_lesional_day43 | 491.48 | 67 |
GSM1296058 | Z_lesional_day43 | 1539.59 | 85 |
GSM1296051 | F_lesional_day43 | 1144.88 | 81 |
GSM1296056 | O_lesional_day43 | 2233.45 | 90 |
GSM1296065 | S_lesional_day43 | 1906.11 | 89 |
GSM1296061 | T_lesional_day43 | 665.42 | 72 |
GSM1296095 | A_non-lesional_pre-dose | 1809.91 | 87 |
GSM1296120 | B_non-lesional_pre-dose | 1579.39 | 86 |
GSM1296077 | C_non-lesional_pre-dose | 711.27 | 74 |
GSM1296093 | D_non-lesional_pre-dose | 520.26 | 68 |
GSM1296104 | E_non-lesional_pre-dose | 1808.33 | 88 |
GSM1296079 | F_non-lesional_pre-dose | 483.21 | 67 |
GSM1296108 | G_non-lesional_pre-dose | 1494.76 | 85 |
GSM1296110 | H_non-lesional_pre-dose | 1136.56 | 82 |
GSM1296081 | I_non-lesional_pre-dose | 569.9 | 70 |
GSM1296091 | J_non-lesional_pre-dose | 1219.8 | 82 |
GSM1296075 | K_non-lesional_pre-dose | 1123.76 | 81 |
GSM1296112 | L_non-lesional_pre-dose | 1313.71 | 84 |
GSM1296100 | M_non-lesional_pre-dose | 1032.78 | 80 |
GSM1296087 | O_non-lesional_pre-dose | 837.54 | 76 |
GSM1296118 | P_non-lesional_pre-dose | 1181.13 | 82 |
GSM1296114 | Q_non-lesional_pre-dose | 1691 | 88 |
GSM1296097 | R_non-lesional_pre-dose | 1328.06 | 83 |
GSM1296106 | S_non-lesional_pre-dose | 1111.96 | 81 |
GSM1296102 | U_non-lesional_pre-dose | 856.56 | 77 |
GSM1296122 | V_non-lesional_pre-dose | 1241.61 | 83 |
GSM1296089 | W_non-lesional_pre-dose | 1059.13 | 80 |
GSM1296083 | X_non-lesional_pre-dose | 579.77 | 70 |
GSM1296116 | Y_non-lesional_pre-dose | 1261.57 | 83 |
GSM1296085 | Z_non-lesional_pre-dose | 633.03 | 71 |